Martin Shkreli violated lifetime pharma industry ban, FTC and states say in contempt claim

Shkreli was banned from the pharmaceutical industry after a trial found that he organized an illegal scheme to perpetuate a monopoly for the drug Daraprim.
Sourcing & attribution. Newseze provides AI-curated summaries, narrative framing, and editorial analysis. The underlying reporting was contributed by CNBC Top News; tap “Open original source” above to read their full reporting and support the contributing newsroom directly.
Newseze's algorithm reads the story and answers your question — calmly, factually, with source attribution. No comments, no flame wars — just answers.
No questions yet. Be the first.
Answers reflect Newseze's editorial framework applied under fair use (17 U.S.C. § 107). Not financial, legal, medical, or tax advice. Hate speech and racial slurs are blocked.
Related stories

Why it mattersAnthropic will release updated financials to a group of investors gathering at its headquarters this week, according to people familiar with the matter.

Why it mattersThe White House has asked U.S. Ambassador to Greece Kimberly Guilfoyle to resign, press secretary Katie Zacharia said Tuesday in her debut briefing.

Why it mattersOne person died and several others were injured in an incident involving the Goliath roller coaster at Six Flags Over Georgia, according to reports.

Why it mattersA Saudi-led coalition fighting the Houthis – a Yemeni militant group backed by Tehran – said it had intercepted another attack on Riyadh.